Trial in japan?
Japanese patents and IP in the news:
This week, Prana Biotechnology received a Japanese composition of matter patent for its leading clinical asset, PBT2, and other selected compounds. As written in the Pharmaceutical Businees Review, “Prana executive chairman Geoffrey Kempler said this decision by the Japanese Office to grant a claim to PBT2 completes a suite of core patent rights protecting this asset in key markets including the US, Europe, Japan and Australia, further bolstering their commercialization plans in both Huntington’s and Alzheimer’s disease.”
http://processandproduction.pharmac...biotechnology-receives-japanese-patent-120411
https://www.articleonepartners.com/blog/international-patent-history-and-laws-japan/
AAIC 2016 talks, page-64
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $4.579K | 1.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 749591 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 133062022 | 26 |
View Market Depth
| Last trade - 14.03pm 13/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |